REFERENCES
1. Praz F, Borger MA, Lanz J, et al. 2025 ESC/EACTS Guidelines for the management of valvular heart disease. Eur Heart J. 2025;46:4635-736.
2. Amicone S, Zannoni J, Barletta M, et al. Transcatheter mitral edge-to-edge repair: a selection of the mitral regurgitation subtype and definition of the optimal time for intervention. Rev Cardiovasc Med. 2025;26:44073.
3. Li Y, Guo XN, Wu Y, et al. Safety and efficacy of novel morphology classification-guided mitral valve transcatheter edge-to-edge repair for patients with commissural degenerative mitral regurgitation: design and rationale of the TEER-CD trial. Rev Cardiovasc Med. 2025;26:39373.
4. Kharsa C, Sammour YM, Bazari R, et al. Outcomes of mitral transcatheter edge-to-edge repair in patients with small mitral valve area. Struct Heart. 2026;10:100772.
5. Nita N, Paukovitsch M, Felbel D, et al. Transcatheter edge-to-edge repair in anatomically complex degenerative mitral regurgitation: 3-year outcomes from a real-world registry. Clin Res Cardiol. 2025;114:904-14.
6. Bhatia K, Gupta S, Carter K, et al. Single-leaflet device attachment after mitral transcatheter edge-to-edge repair: systematic review and meta-analysis. JACC Cardiovasc Interv. 2024;17:2571-4.
7. Neuss M, Schau T, Isotani A, Pilz M, Schöpp M, Butter C. Elevated mitral valve pressure gradient after mitraclip implantation deteriorates long-term outcome in patients with severe mitral regurgitation and severe heart failure. JACC Cardiovasc Interv. 2017;10:931-9.
